A second clinical trial testing fenebrutinib for MS has met its main goal, once again beating approved Aubagio in reducing ...

As columnist Ahna Crum marveled at the feats of Olympic medalists, she decided to grab a pair of ice skates and test her own ...

Paramagnetic rim lesions may help assess MS risk in people with radiologically isolated syndrome before symptoms appear.

Parenting teenagers when you have MS can sometimes end up in a role reversal, Kevin Byrne found when he fell doing chores with his daughter.

Foralumab reduced microglial activity in people with nonactive SPMS, and this was linked to reductions in proinflammatory ...

Donald Kushner says living with MS has made him the gravitational center of his family, and the person in the middle in group ...

Ocrevus (ocrelizumab) and Tysabri (natalizumab) appear equally effective at controlling relapses and MS progression, a study finds.

Researchers mapped myelin-making cells in mice, showing some brain regions recover better after myelin damage.

Merck and Mayo Clinic are partnering to use AI technology and large-scale clinical data to speed drug development in MS and other conditions.

Having parents with a history of smoking is associated with a significantly increased risk of developing pediatric MS, a ...

UCSF is teaming up with Nektar to study NKTR-0165, an experimental antibody that activates the TNFR2 receptor, as a treatment ...

A collaboration will test whether changes in a person’s voice can help detect multiple sclerosis, potentially enabling a ...